Iran Faces Severe Medicine Shortage Amidst US Sanctions
Summary
Iran is facing a severe shortage of medicines as US sanctions and military pressure worsen access to essential drugs, including cancer treatments and insulin. Prices of several commonly used medicines have surged sharply over the past year amid rising inflation.
Key Points
- Iran is experiencing shortages of about 800 types of medicines, including 90 essential and life-saving drugs.
- Prices of common medicines such as Gabapentin, Acetaminophen, Amoxicillin and Fluoxetine have risen sharply over the past year.
- Insulin prices have reportedly increased up to six times, making daily treatment harder for diabetic patients.
- Widespread inflation is also pushing up the prices of essential food items and consumer goods in Iran.
